Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALLOPURINOL Cause Diffuse large b-cell lymphoma recurrent? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with ALLOPURINOL (Allopurinol). This represents 0.1% of all adverse event reports for ALLOPURINOL.

11
Reports of Diffuse large b-cell lymphoma recurrent with ALLOPURINOL
0.1%
of all ALLOPURINOL reports
8
Deaths
0
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma recurrent From ALLOPURINOL?

Of the 11 reports, 8 (72.7%) resulted in death.

Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALLOPURINOL. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does ALLOPURINOL Cause?

Drug reaction with eosinophilia and systemic symptoms (2,943) Acute kidney injury (1,583) Rash (1,103) Off label use (921) Pyrexia (913) Dyspnoea (905) Toxic epidermal necrolysis (858) Pruritus (836) Diarrhoea (819) Drug ineffective (780)

What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?

RITUXIMAB (1,359) CYCLOPHOSPHAMIDE (1,007) VINCRISTINE (957) DOXORUBICIN (953) PREDNISONE (738) CYTARABINE (406) DEXAMETHASONE (402) ETOPOSIDE (375) CISPLATIN (306) GEMCITABINE (280)

Which ALLOPURINOL Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?

ALLOPURINOL vs ALMOTRIPTAN ALLOPURINOL vs ALMOTRIPTAN MALATE ALLOPURINOL vs ALOE VERA LEAF ALLOPURINOL vs ALOGLIPTIN ALLOPURINOL vs ALOGLIPTIN\METFORMIN

Related Pages

ALLOPURINOL Full Profile All Diffuse large b-cell lymphoma recurrent Reports All Drugs Causing Diffuse large b-cell lymphoma recurrent ALLOPURINOL Demographics